{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:31:25Z","timestamp":1761895885750},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T00:00:00Z","timestamp":1406073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s12185-014-1629-4","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T05:02:00Z","timestamp":1406005320000},"page":"281-289","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-term survey of survival time, histological transformation, and secondary malignancies in Japanese patients with advanced-stage follicular lymphoma in the rituximab era: Hokkaido Hematology Study Group"],"prefix":"10.1007","volume":"100","author":[{"given":"Yasuo","family":"Hirayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Ishitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuithi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutoshi","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishu","family":"Takimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Torimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyuhei","family":"Kohda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Kakinoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,23]]},"reference":[{"key":"1629_CR1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"The non-Hodgkin\u2019s lymphoma Classification Project","year":"1997","unstructured":"The non-Hodgkin\u2019s lymphoma Classification Project. A clinical evaluation of International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. Blood. 1997;89:3909\u201315.","journal-title":"Blood"},{"key":"1629_CR2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1440-1827.2000.01108.x","volume":"50","author":"Lymphoma study group of Japanese pathologists","year":"2000","unstructured":"Lymphoma study group of Japanese pathologists. The world health organization classification of malignant lymphomas in japan: incidence of recently recognized eitities. Pathol Int. 2000;50:696\u2013702.","journal-title":"Pathol Int"},{"key":"1629_CR3","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"W Hiddemann","year":"2005","unstructured":"Hiddemann W, Kneba M, Dreyling M, Schmitz N, Lengfelder E, Schmits R, et al. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood. 2005;106:3725\u201332.","journal-title":"Blood"},{"key":"1629_CR4","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1200\/JCO.2007.13.5376","volume":"26","author":"R Marcus","year":"2008","unstructured":"Marcus R, Imrie K, Solal-Celigny P, Catalano JV, Dmoszynska A, Raposo JC, et al. Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma. J Clin Oncol. 2008;26:4579\u201386.","journal-title":"J Clin Oncol."},{"key":"1629_CR5","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1200\/JCO.2005.04.503","volume":"23","author":"WT Swenson","year":"2005","unstructured":"Swenson WT, Wooldridge JE, Lynch CF, Forman-Hoffman VL, Chrischilles E, Link BK. Improved survival of follicular lymphoma patients in the United States. J Clin Oncol. 2005;23:5019\u201326.","journal-title":"J Clin Oncol."},{"key":"1629_CR6","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1111\/j.1349-7006.2010.01703.x","volume":"101","author":"K Tobinai","year":"2010","unstructured":"Tobinai K, Ogura M, Itoh K, Kinoshita T, Hotta T, Watanabe T, et al. Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma: 7-year follow up results. Cancer Sci. 2010;101:2579\u201385.","journal-title":"Cancer Sci"},{"key":"1629_CR7","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1200\/JCO.2011.34.8508","volume":"29","author":"T Watanabe","year":"2011","unstructured":"Watanabe T, Tobinai K, Shibata T, Tsukasaki K, Morishima Y, Maseki N, et al. Phase II\/III study of R-CHOP-21 versus R-CHOP-14 for untreated indolent B-cell non-Hodgkin\u2019s lymphoma: JCOG 0203 trial. J Clin Oncol. 2011;29:3990\u20138.","journal-title":"J Clin Oncol."},{"key":"1629_CR8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2141.2008.07390.x","volume":"143","author":"H Nagai","year":"2008","unstructured":"Nagai H, Yano T, Watanabe T, Uike N, Okamura S, Hanada S, et al. Remission induction therapy containing rituximab markedly improved the outcome of untreated mature B cell lymphoma. Br J Haematol. 2008;143:672\u201380.","journal-title":"Br J Haematol"},{"key":"1629_CR9","unstructured":"Basic resident register in Japan. http:\/\/www.stat.go.jp\/data\/idou\/2011np\/kihon\/pdf\/gaiyou.pdf ."},{"issue":"1","key":"1629_CR10","first-page":"71","volume":"98","author":"Y Torimoto","year":"2013","unstructured":"Torimoto Y, Sato K, Ikuta K, Hayashi T, Hirayama Y, Inamura J, et al. A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group. Int J Hematol. 2013;98(1):71\u20138.","journal-title":"Int J Hematol"},{"key":"1629_CR11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12185-012-1210-y","volume":"96","author":"M Kurosawa","year":"2012","unstructured":"Kurosawa M, Yonezumi M, Hashino S, Tanaka J, Nishio M. Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol. 2012;96:748\u201357.","journal-title":"Int J Hematol"},{"key":"1629_CR12","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.bbmt.2009.03.003","volume":"15","author":"M Onozawa","year":"2009","unstructured":"Onozawa M, Hashino S, Haseyama Y, Hirayama Y, Iizuka S, et al. Incidence and risk of post herpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group. Biol Blood Marrow Transplant. 2009;15:724\u20139.","journal-title":"Biol Blood Marrow Transplant."},{"key":"1629_CR13","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-C\u00e9ligny","year":"2004","unstructured":"Solal-C\u00e9ligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular lymphoma international prognostic index. Blood. 2004;104:1258\u201365.","journal-title":"Blood"},{"key":"1629_CR14","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1200\/JCO.1997.15.3.1110","volume":"15","author":"P Brice","year":"1997","unstructured":"Brice P, Bastion Y, Lepage E, Brousse N, Ha\u00efoun C, et al. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d\u2019Etude des Lymphomes Folliculaires. Groupe d\u2019Etude des Lymphomes de l\u2019Adulte. J Clin Oncol. 1997;15:1110\u20137.","journal-title":"J Clin Oncol"},{"key":"1629_CR15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649\u201355.","journal-title":"Am J Clin Oncol."},{"key":"1629_CR16","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, NCI Sponsored International Working Group, et al. Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. J Clin Oncol. 1999;17:1244\u201353.","journal-title":"J Clin Oncol"},{"key":"1629_CR17","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1200\/JCO.2008.18.8052","volume":"27","author":"TH Keegan","year":"2009","unstructured":"Keegan TH, McClure LA, Foran JM, Clarke CA. Improvements in survival after follicular lymphoma by race\/ethnicity and socioeconomic status: a population-based study. J Clin Oncol. 2009;27:3044\u201351.","journal-title":"J Clin Oncol."},{"key":"1629_CR18","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1200\/JCO.2008.16.4061","volume":"26","author":"AS LaCasce","year":"2008","unstructured":"LaCasce AS, Kho ME, Friedberg JW, Niland JC, Abel GA, Rodriguez MA, et al. Comparison of referring and final pathology for patients with non-Hodgkin\u2019s lymphoma in the National Comprehensive Cancer Network. J Clin Oncol. 2008;26:5107\u201312.","journal-title":"J Clin Oncol."},{"key":"1629_CR19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/asheducation.V2012.1.433.3798541","volume":"2012","author":"B Kahl","year":"2012","unstructured":"Kahl B. Is there a role for \u201cwatch and wait\u201d in follicular lymphoma in the rituximab era? Hematology Am Soc Hematol Educ Progr. 2012;2012:433\u20138.","journal-title":"Hematology Am Soc Hematol Educ Progr."},{"key":"1629_CR20","first-page":"496","volume":"38","author":"N Niitsu","year":"1997","unstructured":"Niitsu N, Umeda M. Prognostic factors of follicular lymphoma treated with combination chemotherapy. Jpn J Clin Hematol. 1997;38:496\u2013504.","journal-title":"Jpn J Clin Hematol."},{"key":"1629_CR21","first-page":"11","volume":"108","author":"K Hiroo","year":"1993","unstructured":"Hiroo K. Clinical studies on 53 cases of follicular lymphomas. Tokyo Jikei Med J. 1993;108:11\u201330.","journal-title":"Tokyo Jikei Med J"},{"key":"1629_CR22","first-page":"2123","volume":"30","author":"T Toshyyuki","year":"1989","unstructured":"Toshyyuki T, Kazumi S, Umihiro S, et al. Follicular lymphoma in Japan: retrospective study on natural history and therapeutic results in 50 cases collected from 4 institutions. Jpn J Clin Oncol. 1989;30:2123\u20138.","journal-title":"Jpn J Clin Oncol"},{"key":"1629_CR23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02981963","volume":"73","author":"E Kondo","year":"2001","unstructured":"Kondo E, Ogura M, Kagami Y, Taji H, Miura K, et al. Assessment of prognostic factors in follicular lymphoma patients. Int J Hematol. 2001;73:363\u20138.","journal-title":"Int J Hematol."},{"key":"1629_CR24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/oxfordjournals.jjco.a023262","volume":"26","author":"N Katsumata","year":"1996","unstructured":"Katsumata N, Matsuno Y, Nakayama H, Takenaka T, Kobayashi Y. Prognostic factors and a predictive model of follicular lymphoma: a 25-year study at a single institution in Japan. Jpn J Clin Oncol. 1996;26:445\u201354.","journal-title":"Jpn J Clin Oncol."},{"key":"1629_CR25","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333","volume":"94","author":"AS Freedman","year":"1999","unstructured":"Freedman AS, Neuberg D, Mauch P. Long-term follow up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. Blood. 1999;94:3325\u201333.","journal-title":"Blood"},{"key":"1629_CR26","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1182\/blood-2007-10-116749","volume":"111","author":"M Ladetto","year":"2008","unstructured":"Ladetto M, De Marco F, Benedetti F, Vitolo U, Patti C, Rambaldi A, et al. Prospective, multicenter randomized GITMO\/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage. Blood. 2008;111:4004\u201313.","journal-title":"Blood"},{"key":"1629_CR27","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2008-05-160200","volume":"113","author":"E Gyan","year":"2009","unstructured":"Gyan E, Foussard C, Bertrand P, Michenet P, Le Gouill S, Berthou C, et al. High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9\u00a0years. Blood. 2009;113:995\u20131001.","journal-title":"Blood"},{"key":"1629_CR28","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2004-03-0982","volume":"104","author":"G Lenz","year":"2004","unstructured":"Lenz G, Dreyling M, Schiegnitz E, Forstpointner R, Wandt H, Freund M, et al. Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group. Blood. 2004;104:2667\u201374.","journal-title":"Blood"},{"key":"1629_CR29","first-page":"1434","volume":"49","author":"M Ogura","year":"2008","unstructured":"Ogura M. Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma. Jpn J Clin Hematol. 2008;49:1434\u201350 (in Japanese).","journal-title":"Jpn J Clin Hematol"},{"key":"1629_CR30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2169\/internalmedicine.48.1368","volume":"48","author":"Y Hirayama","year":"2009","unstructured":"Hirayama Y, Kohda K, Konuma Y, Hirata Y, Kuroda H, Fujimi Y, et al. Late onset neutropenia and immunoglobulin suppression of the patients with malignant lymphoma following autologous stem cell transplantation with\u00a0rituximab. Intern Med. 2009;48:57\u201360.","journal-title":"Intern Med"},{"key":"1629_CR31","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood.V98.13.3595","volume":"98","author":"IF Khouri","year":"2001","unstructured":"Khouri IF, Saliba RM, Giralt SA, Lee MS, Okoroji GJ, Hagemeister FB, et al. Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality. Blood. 2001;98:3595\u20139.","journal-title":"Blood"},{"key":"1629_CR32","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","volume":"27","author":"M Federico","year":"2009","unstructured":"Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol. 2009;27:4555\u201362.","journal-title":"J Clin Oncol."},{"key":"1629_CR33","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","volume":"26","author":"AJ Al-Tourah","year":"2008","unstructured":"Al-Tourah AJ, Gill KK, Chhanabhai PJ, Klasa KJ, Sehnkier TN, et al. Population-based analysis of incidence and outcome of transformed non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2008;26:5165\u201370.","journal-title":"J Clin Oncol."},{"key":"1629_CR34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1182\/blood.V59.2.258.258","volume":"59","author":"SM Hubbard","year":"1982","unstructured":"Hubbard SM, Chabner BA, DeVita VT Jr, Simon R, Berard CW, Jones RB, et al. Histologic progression in non-Hodgkin\u2019s lymphoma. Blood. 1982;59:258\u201364.","journal-title":"Blood"},{"key":"1629_CR35","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1200\/JCO.1995.13.7.1726","volume":"13","author":"AR Yuen","year":"1995","unstructured":"Yuen AR, Kamel OW, Halpern J, Horning SJ. Long-term survival after histologic transformation of low-grade follicular lymphoma. J Clin Oncol. 1995;13:1726\u201333.","journal-title":"J Clin Oncol."},{"key":"1629_CR36","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","volume":"31","author":"BK Link","year":"2013","unstructured":"Link BK, Maurer MJ, Nowakowski GS, Ansell SM, Macon WR. Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa\/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource. J Clin Oncol. 2013;31:3272\u20138.","journal-title":"J Clin Oncol."},{"key":"1629_CR37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1200\/JCO.2007.12.5070","volume":"26","author":"JW Friedberg","year":"2008","unstructured":"Friedberg JW, Cohen P, Chen L, Robinson KS, Forero-Torres A, La Casce AS, et al. Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin\u2019s lymphoma: results from a phase II multicenter, single-agent study. J Clin Oncol. 2008;26:204\u201310.","journal-title":"J Clin Oncol."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1629-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-014-1629-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1629-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T13:06:24Z","timestamp":1598101584000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-014-1629-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,23]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["1629"],"URL":"https:\/\/doi.org\/10.1007\/s12185-014-1629-4","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,23]]}}}